BrightAccountsProduction v1.0.0 v1.0.0 2024-04-01 The company was not dormant during the period The company was trading for the entire period FRS 105 Accounts General medical practice activities 8 August 2025 0 0 09487104 2025-03-31 09487104 2024-03-31 09487104 2023-03-31 09487104 2024-04-01 2025-03-31 09487104 2023-04-01 2024-03-31 09487104 uk-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09487104 uk-curr:PoundSterling 2024-04-01 2025-03-31 09487104 uk-bus:FullAccounts 2024-04-01 2025-03-31 09487104 uk-bus:Director1 2024-04-01 2025-03-31 09487104 uk-bus:RegisteredOffice 2024-04-01 2025-03-31 09487104 uk-bus:Agent1 2024-04-01 2025-03-31 09487104 uk-bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 09487104 uk-core:CapitalReserve 2025-03-31 09487104 uk-core:CapitalReserve 2024-03-31 09487104 2024-04-01 2025-03-31 09487104 uk-bus:Micro-entities 2024-04-01 2025-03-31 xbrli:pure iso4217:GBP xbrli:shares
Company Registration Number: 09487104
 
 
Grove Medical Limited
 
Director's Report and Unaudited Financial Statements
 
for the financial year ended 31 March 2025
Grove Medical Limited
DIRECTOR AND OTHER INFORMATION

 
Director Dr Roberts
 
 
Company Registration Number 09487104
 
 
Registered Office and Business Address 16 Linksview
Wallasey
Wirral
CH45 0NQ
 
 
Accountants Figure Solutions Limited
6 Miller Road
Brymbo
Wrexham
Wrexham
LL11 5FH
GB



Grove Medical Limited
DIRECTOR'S REPORT
for the financial year ended 31 March 2025

 
The director presents their report and the unaudited financial statements for the financial year ended 31 March 2025.
 
Principal Activity and Review of the Business
General medical practice activities
     
Director
The director who served during the financial year is as follows:
     
Dr Roberts
     
There were no changes in shareholdings between 31 March 2025 and the date of signing the financial statements.
     
Statement of Director's Responsibilities
     
The director is responsible for preparing the Director's Report and the financial statements in accordance with applicable law and regulations.
     
Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law) including FRS 105 "The Financial Reporting Standard for Micro-Entities applicable in the UK and Republic of Ireland". Under company law the director must not approve the financial statements unless they is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the director is required to:
- select suitable accounting policies and apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
     
The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
     
Special provisions relating to small companies
The above report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.
     
     
On behalf of the board
     
     
___________________________
Dr Roberts
Director
     
8 August 2025



Grove Medical Limited

ACCOUNTANTS REPORT
to the Director on the Compilation of the unaudited financial statements of Grove Medical Limited
for the financial year ended 31 March 2025
 
In accordance with the engagement letter and in order to assist you to fulfil your duties under the Companies Act 2006, we have compiled for your approval the financial statements of the company for the financial year ended 31 March 2025 as set out on pages 6 to 8 which comprise the Director's Report, Profit and Loss Account, the Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given to us.
 
This report is made solely to the director of Grove Medical Limited, in accordance with the terms of our engagement. Our work has been undertaken so that we might compile the financial statements that we have been engaged to compile, report to the company’s Director that we have done so, and state those matters that we have agreed to state to them in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and its director for our work or for this report.
 
We have carried out this engagement in accordance with guidance issued by and have complied with the relevant ethical guidance laid down by relating to members undertaking the compilation of financial statements.
 
You have acknowledged on the Balance Sheet for the year ended 31 March 2025 your duty to ensure that Grove Medical Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Grove Medical Limited. You consider that Grove Medical Limited is exempt from the statutory audit requirement for the financial year.
 
We have not been instructed to carry out an audit or a review of the financial statements of Grove Medical Limited. For this reason, we have not verified the adequacy, accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
 
 
 
__________________________________
FIGURE SOLUTIONS LIMITED
6 Miller Road
Brymbo
Wrexham
Wrexham
LL11 5FH
GB
 
8 August 2025



Grove Medical Limited
PROFIT AND LOSS ACCOUNT
for the financial year ended 31 March 2025
2025 2024
£ £

Turnover 39,955 47,476
Cost of raw materials and consumables (89) (113)
Staff costs (5,506) (6,036)
Depreciation and other amounts written off assets (833) (568)
Other charges (17,886) (20,981)
───────── ─────────
Profit before taxation 15,641 19,778
Tax (2,964) (3,945)
───────── ─────────
Profit 12,677 15,833
═════════ ═════════



Grove Medical Limited
Company Registration Number: 09487104
BALANCE SHEET
as at 31 March 2025

    2025   2024
  £   £
ASSETS
Fixed Assets 2,497   1,704
Current assets 8,216   8,631
Prepayments and accrued income 1,225   250
  ─────────   ─────────
  11,938   10,585
  ═════════   ═════════
CAPITAL, RESERVES AND LIABILITIES
Capital and Reserves 7,114   5,437
Creditors: amounts falling due within one year 3,824   4,348
Accruals and deferred income 1,000   800
  ─────────   ─────────
  11,938   10,585
  ═════════   ═════════
 
Notes to the Financial statements
   
1. General Information
 
Grove Medical Limited is a company limited by shares incorporated and registered in England. The registered number of the company is 09487104. The registered office of the company is 16 Linksview, Wallasey, Wirral, CH45 0NQ which is also the principal place of business of the company. The financial statements have been presented in Pound (£) which is also the functional currency of the company.
       
2. Employees
 
The average monthly number of employees, including director, during the financial year was 1, (2024 - 1).
   
3. Post-Balance Sheet Events
 
There have been no significant events affecting the company since the financial year-end.
     
For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
 
The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
 
The director acknowledges their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
 
These financial statements have been prepared in accordance with the provisions available to micro-entities in Part 15 of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
 
Approved by the Director on 8 August 2025 and signed by:
 
   
________________________________  
Dr Roberts  
Director